Human Echinococcus disease is a zoonosis that primarily affects the liver and lungs. We report a rare case of hydatid disease in the posterior mediastinum with pseudoaneurysm formation of the descending thoracic aorta and erosion of thoracic vertebral bodies. The patient was surgically treated with removal of multiple daughter cysts and primary repair of the aorta.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2020.08.059DOI Listing

Publication Analysis

Top Keywords

hydatid disease
8
pseudoaneurysm formation
8
formation descending
8
descending thoracic
8
thoracic aorta
8
disease pseudoaneurysm
4
aorta human
4
human echinococcus
4
echinococcus disease
4
disease zoonosis
4

Similar Publications

Hydatid disease is a zoonosis caused by . Vascular complication like rupture of hepatic hydatid cyst into inferior vena cava is extremely rare and potentially life threatening. This report describes a case of a 52-year-old male with spontaneous fistulization of a hepatic hydatid cyst into the inferior vena cava and right hepatic vein.

View Article and Find Full Text PDF

Isolated Cardiac Echinococcosis of Interventricular Septum.

JACC Case Rep

December 2024

Department of Cardiology, GCS Medical College, Hospital & Research Centre, Ahmedabad, Gujarat, India.

Cardiac cystic echinococcosis is a rare form of cystic hydatid disease. Hydatid cysts are multilocular and are picked up incidentally. We here describe a case of an isolated unilocular cardiac hydatid cyst of the interventricular septum with multimodality imaging, treatment approach, and operative findings.

View Article and Find Full Text PDF

Echinococcus granulosus is a zoonotic dog parasite, which causes cystic echinococcosis in humans and animals, adversely affecting health and food production. The resultant socio-economic impacts in lower-middle-income countries and the paucity of epidemiology data prompted the World Health Organization to classify cystic echinococcosis as a neglected tropical disease. Between November 2019 and December 2020, the prevalence of cystic echinococcosis was assessed from 3600 post-slaughter livestock (1142 sheep, 1258 goats and 1200 buffalo) from three districts, Narowal, Sheikhupura and Sialkot, in Northern Punjab, Pakistan.

View Article and Find Full Text PDF

Azvudine and nirmatrelvir-ritonavir (Paxlovid) were widely used to treat patients with COVID-19 in China during the Omicron wave. However, the efficacy and safety of azvudine versus Paxlovid are poorly established. This study included 40,876 hospitalized patients with COVID-19 from eleven hospitals in Henan and Xinjiang Provinces, China.

View Article and Find Full Text PDF

[Controlling cystic echinococcosis: outlook in the 21st centuryControle da equinococose/hidatidose cística: perspectivas no século XXI].

Rev Panam Salud Publica

January 2025

Centro Panamericano de Fiebre Aftosa Unidad de Salud Pública Veterinaria Organización Panamericana de la Salud Río de Janeiro Brasil Centro Panamericano de Fiebre Aftosa, Unidad de Salud Pública Veterinaria, Organización Panamericana de la Salud, Río de Janeiro, Brasil.

Cystic echinococcosis (CE) is a serious public health problem in South America, one that the Pan American Health Organization (PAHO) has included in its Plan of Action for the Control of Neglected Infectious Diseases. A logical framework for CE control was defined: this includes establishing the objective to be achieved (eradication or elimination as a public health problem) and determining levels of endemicity which serve as a guide for establishing frequencies of intervention (high endemicity, endemic, and low endemicity, according to rates in the different hosts). There are two validated tools for CE control: systematic deworming of dogs using praziquantel (PZQ) and systematic vaccination of sheep with recombinant EG95 protein, or a combination of both tools.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!